These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9888640)

  • 1. Kinetics of triglyceride rich lipoproteins: chylomicrons and very low density lipoproteins.
    Hugh P; Barrett R
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S35-40. PubMed ID: 9888640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase.
    Xiang SQ; Cianflone K; Kalant D; Sniderman AD
    J Lipid Res; 1999 Sep; 40(9):1655-63. PubMed ID: 10484612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
    Karpe F
    Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-physiological model of postprandial triglyceride response in lean, obese and very obese individuals after a high-fat meal.
    Leohr J; Heathman M; Kjellsson MC
    Diabetes Obes Metab; 2018 Mar; 20(3):660-666. PubMed ID: 29072819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.
    Nakajima K; Tanaka A
    Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.
    Cooper AD; Shrewsbury MA; Erickson SK
    Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of chylomicrons and VLDL with monoacid-rich triacylglycerol and characterization of kinetic parameters in lipoprotein lipase-mediated hydrolysis in chickens.
    Sato K; Takahashi T; Takahashi Y; Shiono H; Katoh N; Akiba Y
    J Nutr; 1999 Jan; 129(1):126-31. PubMed ID: 9915888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipoprotein metabolism: VLDL vs chylomicrons.
    Nakajima K; Nakano T; Tokita Y; Nagamine T; Inazu A; Kobayashi J; Mabuchi H; Stanhope KL; Havel PJ; Okazaki M; Ai M; Tanaka A
    Clin Chim Acta; 2011 Jul; 412(15-16):1306-18. PubMed ID: 21531214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase. Mechanism of formation of triglyceride-rich remnant particles from very low density lipoproteins and chylomicrons.
    Higgins JM; Fielding CJ
    Biochemistry; 1975 Jun; 14(11):2288-93. PubMed ID: 166652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.
    Karpe F; Bickerton AS; Hodson L; Fielding BA; Tan GD; Frayn KN
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):472-6. PubMed ID: 17511631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.
    Nakajima K; Tokita Y; Tanaka A; Takahashi S
    Clin Chim Acta; 2019 Aug; 495():382-393. PubMed ID: 31078566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
    Bozzetto L; Annuzzi G; Corte GD; Patti L; Cipriano P; Mangione A; Riccardi G; Rivellese AA
    Atherosclerosis; 2011 Jul; 217(1):142-8. PubMed ID: 21481394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
    Nakajima K; Tanaka A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine.
    Tso P; Drake DS; Black DD; Sabesin SM
    Am J Physiol; 1984 Dec; 247(6 Pt 1):G599-610. PubMed ID: 6507617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.
    Taskinen MR; Björnson E; Matikainen N; Söderlund S; Pietiläinen KH; Ainola M; Hakkarainen A; Lundbom N; Fuchs J; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
    Diabetes Obes Metab; 2021 May; 23(5):1191-1201. PubMed ID: 33502078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.